Researcher.Life Logo

International Journal of Pharmaceutical Compounding : Impact Factor & More

pISSN: 1092-4221

Key Metrics

SJR
Q3Medicine (all)
Recommended pre-submission checks
Powered by Paperpal by Editage

International Journal of Pharmaceutical Compounding Journal Specifications

Indexed in the following public directories

  • Scopus Scopus
Overview
Publisher International Journal of Pharmaceutical Compounding (Ijpc)

Looking for the right journals to submit your mansucript?

Upload your manuscript and get a submission readiness score and other journal recommendations.

Check my Paper

Recently Published Papers in International Journal of Pharmaceutical Compounding

Equine Protozoal Myeloencephalitis: An Ancient Parasite Meets Modern Compounding.
  • 1 Feb 2026
  • International journal of pharmaceutical compounding
Nanoemulsion Reformulation of Nitrosylcobalamin (NO-Cbl) Enhances Solubility, Stability, and Anti-Tumor Potency.
  • 1 Feb 2026
  • International journal of pharmaceutical compounding
Between Necessity and Compliance: Understanding FDA's GFI #256 for Animal Drug Compounding.
  • 1 Feb 2026
  • International journal of pharmaceutical compounding
Ethical and Regulatory Implications of Sourcing Drug X During an FDA-Reported Shortage: 503A vs. 503B Compounding Facilities.
  • 1 Feb 2026
  • International journal of pharmaceutical compounding
Chemical and Microbiological Stability Supporting Extended BUDs in Pentravan® Based Transdermal Preparations.
  • 1 Feb 2026
  • International journal of pharmaceutical compounding
Design and Characterization of Doxepin In-situ Nasal Gel Using Pectin as a Bio-compatible Matrix.
  • 1 Feb 2026
  • International journal of pharmaceutical compounding
Equine Protozoal Myeloencephalitis: An Ancient Parasite Meets Modern Compounding.
  • 1 Feb 2026
  • International journal of pharmaceutical compounding
Nanoemulsion Reformulation of Nitrosylcobalamin (NO-Cbl) Enhances Solubility, Stability, and Anti-Tumor Potency.
  • 1 Feb 2026
  • International journal of pharmaceutical compounding
Between Necessity and Compliance: Understanding FDA's GFI #256 for Animal Drug Compounding.
  • 1 Feb 2026
  • International journal of pharmaceutical compounding
Ethical and Regulatory Implications of Sourcing Drug X During an FDA-Reported Shortage: 503A vs. 503B Compounding Facilities.
  • 1 Feb 2026
  • International journal of pharmaceutical compounding
Chemical and Microbiological Stability Supporting Extended BUDs in Pentravan® Based Transdermal Preparations.
  • 1 Feb 2026
  • International journal of pharmaceutical compounding
Design and Characterization of Doxepin In-situ Nasal Gel Using Pectin as a Bio-compatible Matrix.
  • 1 Feb 2026
  • International journal of pharmaceutical compounding

FAQs on International Journal of Pharmaceutical Compounding